← Back to All Trades

REVB

Congressional & insider trading activity

15
Total Trades
1
Traders
0 / 15
Buys / Sells
Distributing
Congress Sentiment
Buy Volume: $0 Sell Volume: $300,000

Recent Trades

Date Trader Type Amount Filed
2026-04-30 Rolke James Insider SELL - 2026-05-01
2026-04-30 Zygmont Chester Stanley III Insider SELL - 2026-05-01
2019-07-31 Patrick J Toomey R SELL $15,001-50,000 -
2018-07-27 Patrick J Toomey R SELL $15,001-50,000 -
2018-06-25 Patrick J Toomey R SELL $1,001-15,000 -
2018-06-06 Patrick J Toomey R SELL $15,001-50,000 -
2018-04-30 Patrick J Toomey R SELL $1,001-15,000 -
2018-03-22 Patrick J Toomey R SELL $1,001-15,000 -
2018-02-08 Patrick J Toomey R SELL $1,001-15,000 -
2018-01-30 Patrick J Toomey R SELL $1,001-15,000 -
2018-01-08 Patrick J Toomey R SELL $1,001-15,000 -
2017-12-07 Patrick J Toomey R SELL $1,001-15,000 -
2017-11-30 Patrick J Toomey R SELL $1,001-15,000 -
2017-11-17 Patrick J Toomey R SELL $1,001-15,000 -
2017-11-15 Patrick J Toomey R SELL $1,001-15,000 -

Top Institutional Holders SEC 13F Filings

Quarterly institutional ownership from 13F-HR filings

Institution Shares Value Report Date
Citadel Advisors LLC 32,400 $285 2026-03-31

Trade-Event Timing Trades near material events

Trades within 7 days before or 3 days after 8-K filings

Rolke James SELL 7d before Results of Operations and Financial Condition (2026-05-07)
Zygmont Chester Stanley III SELL 7d before Results of Operations and Financial Condition (2026-05-07)

Corporate Events SEC 8-K Filings

Material corporate events reported to the SEC

Other Events 8.01,9.01

REVELATION BIOSCIENCES, INC.

2026-06-01 SEC Filing →
Results of Operations and Financial Condition 2.02,9.01

REVELATION BIOSCIENCES, INC.

2026-05-07 SEC Filing →
Material Modification to Rights of Security Holders; Submission of Matters to a Vote 3.03,5.07,9.01

REVELATION BIOSCIENCES, INC.

2026-03-18 SEC Filing →
Results of Operations and Financial Condition 2.02,9.01

REVELATION BIOSCIENCES, INC.

2025-11-06 SEC Filing →

Major Shareholders SEC 13D/13G Filings

Beneficial owners holding 5%+ of outstanding shares

Owner Shares Ownership Filing Type Filing Date
Armistice Capital, LLC SCHEDULE 13G
323,241 7.8% SCHEDULE 13G 2026-05-15
Armistice Capital, LLC SCHEDULE 13G/A
288,332 5.0% SCHEDULE 13G/A 2026-02-17